EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Perrigo Co's enterprise value is $7,405 Mil.
Perrigo Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $4,656 Mil. Therefore, Perrigo Co's EV-to-Revenue for today is 1.59.
The historical rank and industry rank for Perrigo Co's EV-to-Revenue or its related term are showing as below:
PRGO'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.4 Med: 2.69 Max: 7.89
Current: 1.59
During the past 13 years, the highest EV-to-Revenue of Perrigo Co was 7.89. The lowest was 1.40. And the median was 2.69.
PRGO's EV-to-Revenue is ranked better than 64.52% of 1026
companies
in the Drug Manufacturers industry
Industry Median: 2.315
vs PRGO: 1.59
As of today (2024-04-16), Perrigo Co's stock price is $30.20.
Perrigo Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $34.24. Therefore, Perrigo Co's PS Ratio for today is 0.88.
Perrigo Co EV-to-Revenue Historical Data
The historical data trend for Perrigo Co's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Perrigo Co Annual Data
Trend
Jun14
Jun15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
EV-to-Revenue
2.60
2.21
1.70
1.82
1.65
Perrigo Co Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
EV-to-Revenue
1.82
1.88
1.80
1.72
1.65
Competitive Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perrigo Co EV-to-Revenue Distribution
For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Perrigo Co's EV-to-Revenue falls into.
Perrigo Co's current Enterprise Value is $7,405 Mil.
Perrigo Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4,656 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perrigo Co's share price for today is $30.20.
Perrigo Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $34.24.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perrigo Co EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Perrigo Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRGO has been successfully added to your 